Showing results (561-570 of 1,037) with videos related to

Sort By:
Pageof 104
Psychosomatic Medicine|January 3, 2012
Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes studyJavier Labad, Jackie F Price, Mark W J Strachan, et al.
Neurobiology of Aging|October 22, 2010
11β-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive declineAlasdair M J MacLullich, Karen J Ferguson, Louise M Reid, et al.
Molecular Psychiatry|March 8, 2019
The influence of X chromosome variants on trait neuroticismMichelle Luciano, Gail Davies, Kim M Summers, et al.
Genome Medicine|April 30, 2020
Exploratory analysis of age and sex dependent DNA methylation patterns on the X-chromosome in whole blood samplesShuxia Li, Jesper B Lund, Kaare Christensen, et al.
Neuroepidemiology|October 19, 2012
Close correlation between quantitative and qualitative assessments of white matter lesionsMaria del C Valdés Hernández, Zoe Morris, David Alexander Dickie, et al.
Lancet (London, England)|June 11, 2013
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysisKit Yee Chan, Wei Wang, Jing Jing Wu, et al.
Plos One|April 26, 2016
Cognitive Test Scores in UK Biobank: Data Reduction in 480,416 Participants and Longitudinal Stability in 20,346 ParticipantsDonald M Lyall, Breda Cullen, Mike Allerhand, et al.
Plos One|May 21, 2016
Correction: Cognitive Test Scores in UK Biobank: Data Reduction in 480,416 Participants and Longitudinal Stability in 20,346 ParticipantsDonald M Lyall, Breda Cullen, Mike Allerhand, et al.
Magma (New York, N.Y.)|October 15, 2014
Proton spectroscopic imaging of brain metabolites in basal ganglia of healthy older adultsJehill Parikh, Michael J Thrippleton, Catherine Murray, et al.
Psychological Medicine|July 19, 2019
Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measuresMathew A Harris, Xueyi Shen, Simon R Cox, et al.
Pageof 104